This session describes the common neuropsychiatric symptoms of dementia and the factors that may lead to problematic behaviors, as well as defines the appropriate pharmacological roles for cholinesterase inhibitors, NMDA antagonist, antipsychotics, antidepressants, anxiolytic medications, and anti-seizure medications in managing NPSD. Drugs that may not have proven effective or may increase NPSD in clinical practice are identified.
Contact hours available until 3/25/19.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners and Authors Conflict of Interest Disclosure:
Planning Committee: No planning committee member discloses a potential or actual conflict of interest.
Speakers: There are no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or corporate sponsorship was received.
Accreditation Statement: This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and GAPNA.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Learning Outcome: After completing this learning activity, the learner will be able to summarize prescribing considerations for managing the neuropsychiatric symptoms of dementia.